statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid a growing market for glucagon products. With promising sales...

Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd F. Petersen sold 500 shares of the firm's stock in a transaction that occurred on Monday, April 1st. The stock was sold...

Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $21,715.00 in Stock

RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations...

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Advisor Resource Council bought a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH  Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought...

Advisor Resource Council Takes Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

This is a Bullish indicator signaling AMPH's price could rise from here. Traders may explore going long the stock or buying call options...

Amphastar Pharmaceuticals (AMPH, $44.53) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 21, 2024

This is a signal that AMPH's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Amphastar Pharmaceuticals (AMPH, $44.57) RSI Indicator left the oversold zone on March 19, 2024

Lido Advisors LLC lowered its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH  Free Report) by 26.0% in the third quarter, according to the company in its most recent Form 13F filing...

Lido Advisors LLC Sells 1,706 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Amphastar Pharmaceuticals (AMPH, $45.65) RSI Indicator left the oversold zone on March 08, 2024

JPMorgan Chase  Co. initiated coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH  Free Report) in a report issued on Tuesday morning, MarketBeat reports. The brokerage issued an...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at JPMorgan Chase & Co.

Amphastar Pharmaceuticals (AMPH, $46.76) RSI Indicator left the oversold zone on March 07, 2024

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Volume	263,601.00
52-Wk High	$67.66
52-Wk Low	$35.69

AMPH Amphastar Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals